menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

NiKang Therapeutics

Specializing in cancer and autoimmune disease therapies.

NodThera

Develops small molecule inhibitors targeting the NLRP3 inflammasome to treat chronic inflammatory diseases.

Nucleus Genomics

Provides comprehensive DNA testing and analysis to assess health risks by combining genetic data with other medical factors for personalized insights.

Nutcracker Therapeutics-Logo

Nutcracker Therapeutics

Uses high-technology engineering and advanced biosynthesis to advance mRNA therapeutics through strategic partnerships with clinical institutions and pharmaceutical/biotech companies.

Obsidian Therapeutics

A biotechnology company specializing in engineered cell therapies, using gene editing technologies to create personalized treatments that improve immune responses and patient outcomes in the fight against cancer and other diseases.

OM1

Uses clinical data and AI to better understand patient outcomes and personalize patient care.

OncoC4

Biotech company develops innovative immunotherapy treatments that activate the immune system to target and eliminate cancer cells.

One Skin

Develops skincare products with OS-01 peptide to enhance skin health by targeting cellular aging and promoting collagen.

OneSkin

Transforming how skincare works by harnessing a senescence-targeting peptide that rejuvenates skin at the cellular level.

OnKure Therapeutics

Developing innovative cancer therapies, using advanced technology to target specific cancer mechanisms.

Opentrons Labworks Inc-Logo

Opentrons Labworks

A developer of a pipetting robot technology designed to automate experiments.

Orcabio-Logo

Orca Bio

A clinical-stage biotechnology company developing a pipeline of high-precision allogeneic cell therapy products.

Outpace Bio

Develops engineered T cell therapies using AI-powered protein design to enhance immune cell functionality for more effective cancer treatment.

Owkin-Logo

Owkin

Biotechnology company using AI to personalize treatment.

Ozette

AI-powered platform analyzes cytometry data to map immune system patterns and accelerate therapy development through computational analysis.

Palleon Pharmaceuticals

Biotech company develops immunotherapies targeting glycans in tumor environments to enhance natural immune response against cancer

Palvella Therapeutics

Biotech company develops innovative treatments for rare genetic diseases, focusing on mutation-targeted therapies for underserved conditions.

Parse Biosciences

Develops single-cell genomics tools for analyzing biological systems, enabling detailed gene expression and cellular behavior research.